Australia21 is pleased to announce we have been joined by a new Executive Officer, Susan Davidson, who brings outstanding experience and skills to our team. Susan has held leadership positions within several organisations spanning the corporate, government and not-for-profit sectors, most recently with Diabetes Australia.
Neuroscientific research and expert clinical experience show emotions influence every decision we make, so new doctors need to be mindful of the impacts. Dr Lynne Reeder, Founder of Australia21’s Mindful Futures Network, led a symposium on the subject at Melbourne University’s MD Student Conference.
June 2018 is shaping up to be one of Australia21’s busiest months on record! We’ll be taking a good hard look at inequality in Australia, launching a groundbreaking report on PTSD among first responders, and sharing our work on PTSD and mindfulness with doctors of the future.
Manuel Cardoso, the man who reformed Portugal’s drug policy, tells Australians that values including humanism, pragmatism and cooperation were are the heart of the legal change that put a stop to criminal convictions for personal use, reducing direct and indirect drug harms.
The Federal Budget is a reflection of the vision and values of the government of the day. So what does the 2018 Budget say about Australia’s current leadership and the direction it’s setting for our nation? Australia21 has unpacked the policy decisions and the messages they convey, as well as the post-Budget commentary. Now Chair, Paul Barratt, delivers our verdict.
Pill testing at the Groovin the Moo festival in Canberra was only a trial, it didn’t ever claim to be the definitive model for how drug testing should be conducted. Further trials are needed, to provide more quantitative and qualitative data for evaluating the effectiveness in terms of drug harm reduction.
The Greens want to legalise and regulate cannabis for Australians over the age of 18. Their policy announcement has set off alarm bells for many, especially those concerned about young people getting easy access to yet another dangerous drug. But possibly more notable than the objections is the seismic shift in the drug debate.